Published in Eur J Pharmacol on October 05, 2007
Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges. Prim Care Companion CNS Disord (2013) 0.76
An in vitro evaluation of guanfacine as a substrate for P-glycoprotein. Neuropsychiatr Dis Treat (2011) 0.76
Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition. J Child Adolesc Psychopharmacol (2016) 0.75
In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder. J Neural Transm (Vienna) (2012) 0.75
Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci U S A (1980) 7.31
Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A (2000) 5.89
Trends in the prescribing of psychotropic medications to preschoolers. JAMA (2000) 5.02
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2002) 4.57
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest (1995) 3.13
Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control (2003) 2.46
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry (2002) 2.10
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (1995) 1.98
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.91
Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol (2002) 1.60
Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol Sci (2005) 1.59
Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy (2003) 1.57
Concomitant psychotropic medication for youths. Am J Psychiatry (2003) 1.56
Combined pharmacotherapy in children and adolescents in a residential treatment center. J Am Acad Child Adolesc Psychiatry (1997) 1.55
Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants. CNS Drugs (2002) 1.51
Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am (1999) 1.48
Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest (1997) 1.48
Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ (2003) 1.47
The stimulants. Psychiatr Clin North Am (1992) 1.29
Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet (2006) 1.26
Stimulant medications. J Am Acad Child Adolesc Psychiatry (1999) 1.25
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry (2003) 1.19
Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism. Drug Metab Dispos (2003) 1.18
In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci (2002) 1.11
Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol (2004) 1.09
The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci (1997) 1.07
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacology (Berl) (2004) 1.04
Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects. Biol Psychiatry (1987) 1.01
Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding. Biochem J (2004) 0.98
Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals. Neuropsychopharmacology (2004) 0.97
Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. Clin Pharmacokinet (2001) 0.95
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl) (2006) 0.95
Risperidone and paliperidone inhibit p-glycoprotein activity in vitro. Neuropsychopharmacology (2006) 0.94
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana. J Pharmacol Exp Ther (2006) 0.94
Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci (2000) 0.93
Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J Am Acad Child Adolesc Psychiatry (2001) 0.91
The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine. Drug Metab Dispos (2006) 0.87
Transporters and their impact on drug disposition. Ann Pharmacother (2005) 0.87
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. Clin Pharmacol Ther (2005) 0.85
Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.82
Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). J Neural Transm (Vienna) (2005) 0.81
Rhodamine 123 accumulates extensively in the isolated perfused rat kidney and is secreted by the organic cation system. Eur J Pharmacol (1997) 0.80
Apparent active transport of MDMA is not mediated by P-glycoprotein: a comparison with MDCK and Caco-2 monolayers. Biopharm Drug Dispos (2006) 0.78
Chiral analysis of d- and l-modafinil in human serum: application to human pharmacokinetic studies. Ther Drug Monit (2003) 0.78
Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res (2005) 3.56
The changing face of HIV in China. Nature (2008) 3.39
Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity (2012) 2.47
Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother (2011) 2.39
Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS (2006) 2.36
Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother (2009) 2.33
HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin Infect Dis (2013) 2.24
The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol (2012) 2.11
Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc Natl Acad Sci U S A (2010) 2.06
Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA (2003) 1.93
Characterization of ST-4821 complex, a unique Neisseria meningitidis clone. Genomics (2007) 1.59
Quantum teleportation and entanglement distribution over 100-kilometre free-space channels. Nature (2012) 1.56
Tetraethyl 2,2'-(2,3,5,6-tetrafluoro-p-phenylenedimethylene)dipropanoate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.53
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet (2008) 1.50
Complete genome sequence of bacteriophage T5. Virology (2005) 1.48
Intrinsic left atrial histoanatomy as the basis for reentrant excitation causing atrial fibrillation/flutter in rats. Heart Rhythm (2013) 1.46
Chromatin immunoprecipitation in postmortem brain. J Neurosci Methods (2006) 1.43
Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol (2007) 1.41
Finasteride adherence-associated factors in Chinese benign prostatic hyperplasia patients. Urol Int (2011) 1.41
1,1,3-Trimethyl-3-phenyl-indane. Acta Crystallogr Sect E Struct Rep Online (2008) 1.41
Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively. Drug Metab Dispos (2002) 1.40
Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. BMC Cancer (2013) 1.40
Complete nucleotide sequence of pKP96, a 67 850 bp multiresistance plasmid encoding qnrA1, aac(6')-Ib-cr and blaCTX-M-24 from Klebsiella pneumoniae. J Antimicrob Chemother (2008) 1.40
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry (2007) 1.38
Analysis of homeostasis model assessment-insulin resistance HOMA-IR in healthy young Chinese adults. Saudi Med J (2010) 1.38
Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp. in China. J Antimicrob Chemother (2012) 1.36
How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr (2004) 1.33
Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res (2004) 1.31
ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Dev Cell (2010) 1.31
Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res (2012) 1.30
Cocoa and health: a decade of research. Br J Nutr (2007) 1.30
Pharmacist-conducted medication reconciliation in an emergency department. Am J Health Syst Pharm (2007) 1.28
Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route. BMC Public Health (2010) 1.23
AtECB2, a pentatricopeptide repeat protein, is required for chloroplast transcript accD RNA editing and early chloroplast biogenesis in Arabidopsis thaliana. Plant J (2009) 1.22
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Drug Metab Dispos (2003) 1.22
Cell cycle- and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor. J Biol Chem (2006) 1.22
Metabolism of dietary procyanidins in rats. Free Radic Biol Med (2003) 1.22
Suspended moxibustion relieves chronic visceral hyperalgesia via serotonin pathway in the colon. Neurosci Lett (2008) 1.21
Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Eur J Clin Pharmacol (2002) 1.20
1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol (2008) 1.19
Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay. J Virol Methods (2005) 1.16
Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation. J Pharmacol Exp Ther (2012) 1.16
Early infant human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots. J Clin Microbiol (2007) 1.16
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers. J Clin Psychopharmacol (2002) 1.15
Modafinil and cocaine interactions. Am J Drug Alcohol Abuse (2006) 1.14
Repeated exposure to propofol potentiates neuroapoptosis and long-term behavioral deficits in neonatal rats. Neurosci Lett (2013) 1.13
HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China. Int J Infect Dis (2007) 1.13
Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents (2013) 1.12
Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro. Basic Clin Pharmacol Toxicol (2006) 1.11
In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci (2002) 1.11
A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol (2006) 1.10
High-average-power 2-kHz laser for generation of ultrashort x-ray pulses. Opt Lett (2002) 1.09
Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids. Nature (2012) 1.09
Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter. Am J Physiol Gastrointest Liver Physiol (2002) 1.08
Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril. Biochem Pharmacol (2009) 1.08
Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants. Drug Metab Dispos (2008) 1.07
Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver. Drug Metab Dispos (2009) 1.06
Seroincidence of recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immunol (2007) 1.06
Effect of transglutaminase treatment on the properties of cast films of soy protein isolates. J Biotechnol (2005) 1.05
Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. Liver Transpl (2005) 1.04
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacology (Berl) (2004) 1.04
Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy (2004) 1.04
Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells. Hum Reprod Update (2010) 1.04
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Mol Syst Biol (2013) 1.03
An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells. Arch Physiol Biochem (2006) 1.02
A noninterference polypyrrole glucose biosensor. Biosens Bioelectron (2006) 1.01
Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Clin Ther (2007) 1.01
A novel cost-effective technology to convert sucrose and homocelluloses in sweet sorghum stalks into ethanol. Biotechnol Biofuels (2013) 1.01
Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China. Transfusion (2009) 1.00
Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China. J Antimicrob Chemother (2011) 1.00
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein. Int J Neuropsychopharmacol (2004) 0.99
Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J Nutr (2003) 0.99
Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice. J Bone Miner Res (2014) 0.99
New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Drug Deliv (2005) 0.99
Placental passage of tricyclic antidepressants. Biol Psychiatry (2005) 0.99
Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China. J Infect (2006) 0.99
Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. J Clin Invest (2013) 0.98
Cx43 contributes to TGF-beta signaling to regulate differentiation of cardiac fibroblasts into myofibroblasts. Exp Cell Res (2009) 0.98
Child body mass index in four cities of East China compared to Western references. Ann Hum Biol (2008) 0.98
Adverse drug events after hospital discharge in older adults: types, severity, and involvement of Beers Criteria Medications. J Am Geriatr Soc (2013) 0.97
Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals. Neuropsychopharmacology (2004) 0.97
Drug use and sex work: competing risk factors for newly acquired HIV in Yunnan, China. PLoS One (2013) 0.96
Cloning and functional identification of two members of the ZIP (Zrt, Irt-like protein) gene family in rice (Oryza sativa L.). Mol Biol Rep (2007) 0.96